- Home
- IMUX vs WETO Comparison
IMUX vs WETO Comparison
Compare IMUX & WETO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMUX
- WETO
- Stock Information
- Founded
- IMUX 2016
- WETO 2019
- Country
- IMUX United States
- WETO China
- Employees
- IMUX N/A
- WETO N/A
- Industry
- IMUX Biotechnology: Pharmaceutical Preparations
- WETO
- Sector
- IMUX Health Care
- WETO
- Exchange
- IMUX Nasdaq
- WETO NYSE
- Market Cap
- IMUX 90.3M
- WETO 81.4M
- IPO Year
- IMUX N/A
- WETO 2025
- Fundamental
- Price
- IMUX $0.98
- WETO $3.90
- Analyst Decision
- IMUX Strong Buy
- WETO
- Analyst Count
- IMUX 6
- WETO 0
- Target Price
- IMUX $13.20
- WETO N/A
- AVG Volume (30 Days)
- IMUX 661.4K
- WETO 22.1K
- Earning Date
- IMUX 05-07-2025
- WETO 01-01-0001
- Dividend Yield
- IMUX N/A
- WETO N/A
- EPS Growth
- IMUX N/A
- WETO N/A
- EPS
- IMUX N/A
- WETO N/A
- Revenue
- IMUX N/A
- WETO $6,326,827.00
- Revenue This Year
- IMUX N/A
- WETO N/A
- Revenue Next Year
- IMUX N/A
- WETO N/A
- P/E Ratio
- IMUX N/A
- WETO N/A
- Revenue Growth
- IMUX N/A
- WETO N/A
- 52 Week Low
- IMUX $0.83
- WETO $3.10
- 52 Week High
- IMUX $2.11
- WETO $4.28
- Technical
- Relative Strength Index (RSI)
- IMUX 45.24
- WETO N/A
- Support Level
- IMUX $0.86
- WETO N/A
- Resistance Level
- IMUX $1.01
- WETO N/A
- Average True Range (ATR)
- IMUX 0.09
- WETO 0.00
- MACD
- IMUX -0.01
- WETO 0.00
- Stochastic Oscillator
- IMUX 42.53
- WETO 0.00
About IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.
About WETO WEBUS INTERNATIONAL LIMITED
Webus International Ltd operates on a business model of Mobility-as-a-Service to identify and solve inefficiencies associated with inflexible or low-quality public transportation and provide cost-efficient and customized mass transportation services under different scenarios with comprehensive digital platforms. It offers commute shuttle service, customized chartered bus service, packaged tour service and other service to customers.